Filing Details

Accession Number:
0001140361-12-025920
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-16 21:26:01
Reporting Period:
2012-05-14
Filing Date:
2012-05-16
Accepted Time:
2012-05-16 20:26:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
943819 Resmed Inc RMD Surgical & Medical Instruments & Apparatus (3841) 980152841
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186678 A Michael Quinn Resmed Inc.
9001 Spectrum Center Blvd.
San Diego CA 92123
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Resmed Common Stock Acquisiton 2012-05-14 12,000 $23.10 314,000 No 4 M Direct
Resmed Common Stock Disposition 2012-05-14 12,000 $33.30 302,000 No 4 S Direct
Resmed Common Stock Acquisiton 2012-05-14 12,000 $9.80 314,000 No 4 M Direct
Resmed Common Stock Disposition 2012-05-14 12,000 $33.26 302,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Resmed Common Stock ResMed Common Stock Options Disposition 2012-05-14 24,000 $0.00 24,000 $23.10
24,000 ResMed Common Stock Options Disposition 2012-05-14 24,000 $0.00 24,000 $9.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-11-10 2013-11-10 No 4 M Direct
12,000 2004-07-07 2013-07-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Asx Cdis 400,000 Direct
Resmed Common Stock 6,600 Indirect Kaylara ATF Straflo Pension Fund
Footnotes
  1. Represents date options first became exercisable. Options vest 1/12 per month and are fully vested at one year.
  2. Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.
  3. This transaction was executed in multiple trades at prices ranging from $33.26 and 33.31. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
  4. Previously reported as 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.